Skip to main content
. 2017 Apr 6;8(30):48948–48958. doi: 10.18632/oncotarget.16896

Figure 5. The correlation between the expression levels of ABAT, AGXT, ALDH6A1, CYP4A11, DAO and EHHADH and the disease progression of hepatocellular carcinoma (HCC) (based on microarray data of GSE6764).

Figure 5

Stage: 1 for very early HCC, 2 for early HCC, 3 for advanced HCC, and 4 for very advanced HCC.